Cell Press and Lancet Journals on ScienceDirect

» Access: On campus within UP System, Domain-based Access (see this page), or remote via OpenAthens
Trial period: 01 April to 31 May 2022 (extended until 17 June 2022)

Cell Press publishes over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. The following journals from Cell Press are included in this trial:

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue ​in ​Oct​ober​ 5, 1823, the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people.​ ​The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives.​ Titles on trial from The Lancet family include:​